| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | Jun 23, 2025 | Savara Inc | Director | Buy | 95.0 | +48,225 | 71.72% | ✗ | $98.6K |
| Dec 12, 2024 | Dec 16, 2024 | Savara Inc | Director | Sell | 91.3 | +32,000 | 90.80% | ✗ | $26.6K |
| Sep 13, 2024 | Sep 17, 2024 | PLUS THERAPEUTICS, INC. | Director | Buy | 90.0 | +4,000 | 35.75% | ✗ | $6K |
| Sep 12, 2024 | Sep 16, 2024 | PLUS THERAPEUTICS, INC. | Director | Buy | 90.0 | +6,285 | 128.19% | ✗ | $8.5K |
| May 8, 2024 | May 10, 2024 | PLUS THERAPEUTICS, INC. | Director | Buy | 91.3 | +4,902 | 490200.00% | ✗ | $10K |
| Mar 3, 2023 | Mar 6, 2023 | PLUS THERAPEUTICS, INC. | Director | Buy | 90.0 | +1 | 100.00% | ✗ | $1K |
| May 14, 2019 | May 16, 2019 | Savara Inc | Director | Sell | 20.0 | -25,000 | -100.00% | ✗ | $277.6K |